US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Septerna, Inc.

37.37

-0.3100-0.82%

Volume:135.33K

Turnover:5.10M

Market Cap:1.74B

PE:-68.89

High:38.86

Open:37.96

Low:37.25

Close:37.68

52wk High:51.10

52wk Low:11.98

Shares:46.68M

Float Shares:22.90M

Volume Ratio:0.55

T/O Rate:0.59%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5424

EPS(LYR):-1.1044

ROE:-6.34%

ROA:-7.13%

PB:4.51

PE(LYR):-33.84

Loading ...

Overview Company News Filings

Septerna to Participate in Upcoming Investor Conferences

Septerna (SEPN) Names A New CMO, Is The Upside Already Priced In?

Simply Wall St.

Is Septerna (SEPN) Elevating Its Clinical Strategy With a Veteran Regulatory Leader at the Helm?

Simply Wall St.

Press Release: Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer

Septerna is Maintained at Overweight by JP Morgan

Septerna price target raised to $48 from $38 at JPMorgan

U.S. Research Roundup-Cogent Communications, Dollar Tree, Home Depot

Septerna, Inc. (SEPN) Receives a Rating Update from a Top Analyst

Truist Financial Reaffirms Their Buy Rating on Septerna, Inc. (SEPN)

Septerna President, COO Elizabeth Bhatt Sells 25,000 Shares Worth $1.1 Million Under 10b5-1 Plan

Does Septerna (SEPN) Pair Narrowing Losses With A Cash Runway That Truly Supports Its Pipeline Strategy?

Simply Wall St.

Septerna, Inc. : Wells Fargo Raises Target Price to $50 from $48

THOMSON REUTERS

Wall Street Analysts Are Bullish on Top NA Picks

Septerna is Maintained at Buy by Guggenheim

Septerna price target raised to $49 from $45 at Raymond James

C4 Therapeutics Q2 Revenue Beats Estimates, Helped by Roche Collaboration

Septerna Q2 Loss Narrows, Revenue Rises

MT Newswires Live

Septerna, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Earnings Flash (SEPN) Septerna Posts Q2 Loss Per Share $0.29, vs. FactSet Est of $0.43 Loss

MT Newswires Live

Septerna Q2 Revenue Beats Analyst Estimates, Driven by Novo Nordisk Partnership

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/SEPN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SEPN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SEPN\",,,,,undefined,":{"symbol":"SEPN","market":"US","secType":"STK","nameCN":"Septerna, Inc.","latestPrice":37.37,"timestamp":1788374944557,"preClose":37.68,"halted":0,"volume":135327,"delay":0,"changeRate":-0.008227176220806855,"floatShares":22896300,"shares":46676947,"eps":-0.542426,"marketStatus":"Trading","change":-0.31,"latestTime":"09-02 14:49:07 EDT","open":37.96,"high":38.86,"low":37.245,"amount":5095661.589918001,"amplitude":0.042861,"askPrice":37.52,"askSize":2,"bidPrice":37.38,"bidSize":37,"shortable":3,"etf":0,"ttmEps":-0.542426,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"listingDate":1729828800000,"exchange":"NASDAQ","adjPreClose":37.68,"postHourTrading":{"tag":"盘后","latestPrice":37.68,"preClose":37.68,"latestTime":"19:30 EDT","volume":5919,"amount":223027.92,"timestamp":1788305406601,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.549691,"impliedVol":0.8032,"impliedVolPercentile":0.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SEPN\",,,,,undefined,":{"symbol":"SEPN","floatShares":22896300,"roa":"-7.13%","roe":"-6.34%","lyrEps":-1.104402,"volumeRatio":0.549691,"shares":46676947,"dividePrice":0,"high":38.86,"amplitude":0.042861,"preClose":37.68,"low":37.245,"week52Low":11.98,"pbRate":"4.51","psRate":"17.64","week52High":51.1,"institutionHeld":0,"latestPrice":37.37,"committee":0.897436,"eps":-0.542426,"divideRate":0,"volume":135327,"delay":0,"ttmEps":-0.542426,"open":37.96,"prevYearClose":27.88,"prevWeekClose":38.91,"prevMonthClose":38.15,"prevQuarterClose":33.49,"fiveDayClose":40.25,"twentyDayClose":38.76,"sixtyDayClose":30.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SEPN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"SEPN","fiscalQuarterEnding":"2026/06","expectedEps":-0.48,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2026-05-11","symbol":"SEPN","fiscalQuarterEnding":"2026/03","expectedEps":-0.51,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-0.19},{"market":"US","date":"2026-03-09","symbol":"SEPN","fiscalQuarterEnding":"2025/12","expectedEps":-0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"post","actualEps":-0.24},{"market":"US","date":"2025-11-10","symbol":"SEPN","fiscalQuarterEnding":"2025/09","expectedEps":0.19,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.09},{"market":"US","date":"2025-08-11","symbol":"SEPN","fiscalQuarterEnding":"2025/06","expectedEps":-0.05,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.56}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SEPN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SEPN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.7,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7,"analysts":10,"updateTime":1781236800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SEPN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SEPN","date":"2026-09-01","current":-68.89419,"percent":0.032609,"low":-92.81078,"twenty":-42.526647,"median":-19.764628,"eighty":-6.109088,"high":261.261398,"avg":-15.174639,"sd":53.482573,"marketCap":1780725528},"quantilePoints":[{"date":"2024-10-25","current":180.873276,"twenty":180.873276,"median":180.873276,"eighty":180.873276,"marketCap":756050292},{"date":"2024-10-31","current":204.688257,"twenty":197.111676,"median":204.688257,"eighty":209.813,"marketCap":855596913},{"date":"2024-11-08","current":261.261398,"twenty":203.984861,"median":216.997688,"eighty":242.57116,"marketCap":1092072644},{"date":"2024-11-15","current":224.885772,"twenty":207.743006,"median":230.613426,"eighty":256.156752,"marketCap":940022529},{"date":"2024-11-22","current":-56.371082,"twenty":203.984861,"median":228.503238,"eighty":245.706296,"marketCap":915240881},{"date":"2024-11-29","current":-69.163916,"twenty":-57.105794,"median":221.92146,"eighty":240.581553,"marketCap":1122945345},{"date":"2024-12-06","current":-68.890433,"twenty":-66.926823,"median":208.506693,"eighty":237.707678,"marketCap":1118505070},{"date":"2024-12-13","current":-61.725172,"twenty":-67.501138,"median":191.022276,"eighty":236.763117,"marketCap":1002169886},{"date":"2024-12-20","current":-63.995083,"twenty":-66.784612,"median":-58.207863,"eighty":234.592638,"marketCap":1039024162},{"date":"2024-12-27","current":-70.449288,"twenty":-68.420042,"median":-60.166317,"eighty":232.180994,"marketCap":1143814633},{"date":"2025-01-03","current":-58.388676,"twenty":-68.655237,"median":-61.232902,"eighty":229.769351,"marketCap":947998541},{"date":"2025-01-10","current":-57.02126,"twenty":-67.714455,"median":-60.412452,"eighty":226.39305,"marketCap":925797170},{"date":"2025-01-17","current":-46.437457,"twenty":-67.358927,"median":-58.853597,"eighty":224.885772,"marketCap":753958559},{"date":"2025-01-24","current":-50.266223,"twenty":-66.593173,"median":-57.614562,"eighty":220.142874,"marketCap":816122397},{"date":"2025-01-31","current":-48.433885,"twenty":-66.401735,"median":-55.982023,"eighty":215.822012,"marketCap":786372560},{"date":"2025-02-07","current":-38.861971,"twenty":-65.110894,"median":-50.840537,"eighty":209.813,"marketCap":630962963},{"date":"2025-02-14","current":-31.587316,"twenty":-64.153703,"median":-49.199638,"eighty":205.451944,"marketCap":512851670},{"date":"2025-02-21","current":-16.108164,"twenty":-63.748948,"median":-46.492154,"eighty":202.578068,"marketCap":261532150},{"date":"2025-02-28","current":-15.862029,"twenty":-63.55204,"median":-46.410109,"eighty":188.992476,"marketCap":257535903},{"date":"2025-03-07","current":-17.393535,"twenty":-63.169163,"median":-46.191322,"eighty":63.291545,"marketCap":282401439},{"date":"2025-03-14","current":-17.47558,"twenty":-62.928498,"median":-43.237703,"eighty":-15.145503,"marketCap":283733521},{"date":"2025-03-21","current":-16.81922,"twenty":-62.747999,"median":-39.764466,"eighty":-15.424456,"marketCap":273076863},{"date":"2025-03-28","current":-3.893469,"twenty":-62.08617,"median":-37.439858,"eighty":-15.424456,"marketCap":279543299},{"date":"2025-04-04","current":-3.590162,"twenty":-61.462628,"median":-35.44343,"eighty":-3.701581,"marketCap":257766476},{"date":"2025-04-11","current":-3.194007,"twenty":-61.271189,"median":-31.04035,"eighty":-3.397655,"marketCap":229323279},{"date":"2025-04-17","current":-3.707771,"twenty":-61.249311,"median":-18.610536,"eighty":-3.429843,"marketCap":266210551},{"date":"2025-04-25","current":-3.998698,"twenty":-60.904722,"median":-17.913153,"eighty":-3.49979,"marketCap":287098524},{"date":"2025-05-02","current":-4.419614,"twenty":-60.313998,"median":-17.530277,"eighty":-3.557975,"marketCap":317319421},{"date":"2025-05-09","current":-4.302005,"twenty":-59.827198,"median":-17.393535,"eighty":-3.586448,"marketCap":308875347},{"date":"2025-05-16","current":-5.700187,"twenty":-58.946582,"median":-17.1474,"eighty":-3.607494,"marketCap":450930380},{"date":"2025-05-23","current":-5.339701,"twenty":-58.316351,"median":-16.81922,"eighty":-3.64092,"marketCap":422413044},{"date":"2025-05-30","current":-5.553739,"twenty":-57.970542,"median":-16.682479,"eighty":-3.660728,"marketCap":439345212},{"date":"2025-06-06","current":-5.925491,"twenty":-56.891224,"median":-16.203883,"eighty":-3.697867,"marketCap":468753715},{"date":"2025-06-13","current":-5.863532,"twenty":-56.29327,"median":-16.053467,"eighty":-3.717675,"marketCap":463852298},{"date":"2025-06-20","current":-5.908593,"twenty":-55.982023,"median":-15.862029,"eighty":-3.757291,"marketCap":467416965},{"date":"2025-06-27","current":-6.122632,"twenty":-53.001056,"median":-15.383433,"eighty":-3.77586,"marketCap":484349134},{"date":"2025-07-03","current":-6.404261,"twenty":-51.513306,"median":-10.750269,"eighty":-3.795668,"marketCap":506628303},{"date":"2025-07-11","current":-6.578872,"twenty":-50.660039,"median":-6.404261,"eighty":-3.874899,"marketCap":520441387},{"date":"2025-07-18","current":-7.108336,"twenty":-50.32092,"median":-6.590137,"eighty":-3.893469,"marketCap":562326225},{"date":"2025-07-25","current":-7.6378,"twenty":-49.412955,"median":-6.753482,"eighty":-3.9727,"marketCap":604211063},{"date":"2025-08-01","current":-6.990051,"twenty":-48.587036,"median":-6.961888,"eighty":-3.99746,"marketCap":552968974},{"date":"2025-08-08","current":-6.590137,"twenty":-46.8805,"median":-6.764747,"eighty":-3.998698,"marketCap":521332554},{"date":"2025-08-15","current":-5.951139,"twenty":-46.492154,"median":-6.643647,"eighty":-4.11805,"marketCap":520754376},{"date":"2025-08-22","current":-5.961329,"twenty":-46.448396,"median":-6.601402,"eighty":-4.167728,"marketCap":521646079},{"date":"2025-08-29","current":-6.256848,"twenty":-46.3937,"median":-6.581688,"eighty":-4.266238,"marketCap":547505457},{"date":"2025-09-05","current":-7.194356,"twenty":-46.300716,"median":-6.581688,"eighty":-4.297053,"marketCap":629542106},{"date":"2025-09-12","current":-7.34721,"twenty":-46.213201,"median":-6.601402,"eighty":-4.305719,"marketCap":642917646},{"date":"2025-09-19","current":-8.121674,"twenty":-44.993466,"median":-6.643647,"eighty":-4.319893,"marketCap":710687051},{"date":"2025-09-26","current":-8.534381,"twenty":-43.94876,"median":-6.764747,"eighty":-4.33085,"marketCap":746801011},{"date":"2025-10-03","current":-10.266733,"twenty":-43.12831,"median":-6.961888,"eighty":-4.351524,"marketCap":898390470},{"date":"2025-10-10","current":-11.790184,"twenty":-42.592283,"median":-7.068908,"eighty":-4.39733,"marketCap":1031700023},{"date":"2025-10-17","current":-11.497212,"twenty":-40.869338,"median":-7.146788,"eighty":-4.427042,"marketCap":1006063571},{"date":"2025-10-24","current":-11.102338,"twenty":-39.518331,"median":-7.194356,"eighty":-4.55084,"marketCap":971510091},{"date":"2025-10-31","current":-10.949483,"twenty":-39.058879,"median":-7.339567,"eighty":-4.913908,"marketCap":958134551},{"date":"2025-11-07","current":-9.578887,"twenty":-37.155435,"median":-7.357401,"eighty":-5.147066,"marketCap":838200538},{"date":"2025-11-14","current":-14.648361,"twenty":-35.886473,"median":-7.487327,"eighty":-5.196633,"marketCap":861455454},{"date":"2025-11-21","current":-18.097273,"twenty":-35.585642,"median":-7.6378,"eighty":-5.267603,"marketCap":1064282543},{"date":"2025-11-28","current":-22.094357,"twenty":-33.900984,"median":-7.78988,"eighty":-5.319423,"marketCap":1299347051},{"date":"2025-12-05","current":-19.916898,"twenty":-31.401348,"median":-8.060532,"eighty":-5.378003,"marketCap":1171292862},{"date":"2025-12-12","current":-19.954966,"twenty":-31.056759,"median":-8.182815,"eighty":-5.451226,"marketCap":1173531572},{"date":"2025-12-19","current":-20.96756,"twenty":-27.412726,"median":-8.753473,"eighty":-5.501919,"marketCap":1233081247},{"date":"2025-12-26","current":-22.436964,"twenty":-22.503963,"median":-9.413294,"eighty":-5.544727,"marketCap":1319495438},{"date":"2026-01-02","current":-21.226419,"twenty":-22.436964,"median":-9.632386,"eighty":-5.553739,"marketCap":1248304472},{"date":"2026-01-09","current":-19.597131,"twenty":-22.436964,"median":-9.915167,"eighty":-5.569002,"marketCap":1152487702},{"date":"2026-01-16","current":-20.845744,"twenty":-22.436964,"median":-10.381374,"eighty":-5.593168,"marketCap":1225917376},{"date":"2026-01-23","current":-20.305186,"twenty":-22.162878,"median":-10.567347,"eighty":-5.611192,"marketCap":1194127700},{"date":"2026-01-30","current":-18.120114,"twenty":-22.094357,"median":-10.857771,"eighty":-5.615698,"marketCap":1065625769},{"date":"2026-02-06","current":-18.607377,"twenty":-21.850725,"median":-11.071767,"eighty":-5.615698,"marketCap":1094281252},{"date":"2026-02-13","current":-19.612358,"twenty":-21.722819,"median":-11.209336,"eighty":-5.64356,"marketCap":1153383185},{"date":"2026-02-20","current":-20.61734,"twenty":-21.739568,"median":-11.372381,"eighty":-5.676942,"marketCap":1212485119},{"date":"2026-02-27","current":-23.053657,"twenty":-22.094357,"median":-11.478105,"eighty":-5.697934,"marketCap":1355762533},{"date":"2026-03-06","current":-20.914266,"twenty":-22.094357,"median":-11.754518,"eighty":-5.704017,"marketCap":1229947054},{"date":"2026-03-13","current":-24.295691,"twenty":-22.288862,"median":-11.879349,"eighty":-5.719638,"marketCap":1187549060},{"date":"2026-03-20","current":-22.30665,"twenty":-22.436964,"median":-13.780423,"eighty":-5.741868,"marketCap":1090326760},{"date":"2026-03-27","current":-22.729264,"twenty":-22.436964,"median":-14.644554,"eighty":-5.761019,"marketCap":1110983692},{"date":"2026-04-02","current":-22.389336,"twenty":-22.436964,"median":-14.872318,"eighty":-5.77679,"marketCap":1094368334},{"date":"2026-04-10","current":-22.811949,"twenty":-22.645844,"median":-15.588546,"eighty":-5.790308,"marketCap":1115025266},{"date":"2026-04-17","current":-22.958945,"twenty":-22.751313,"median":-15.862029,"eighty":-5.81451,"marketCap":1122210286},{"date":"2026-04-24","current":-22.940571,"twenty":-22.897489,"median":-16.108164,"eighty":-5.8559,"marketCap":1121312158},{"date":"2026-05-01","current":-21.828913,"twenty":-22.897489,"median":-16.346578,"eighty":-5.87705,"marketCap":1066975446},{"date":"2026-05-08","current":-22.031033,"twenty":-22.828174,"median":-16.573085,"eighty":-5.90051,"marketCap":1076854848},{"date":"2026-05-15","current":-35.420064,"twenty":-23.014069,"median":-16.805546,"eighty":-5.906606,"marketCap":1276539094},{"date":"2026-05-22","current":-34.91978,"twenty":-23.096754,"median":-17.065355,"eighty":-5.913099,"marketCap":1258508881},{"date":"2026-05-29","current":-38.834498,"twenty":-23.422893,"median":-17.338839,"eighty":-5.920985,"marketCap":1399595299},{"date":"2026-06-05","current":-39.234724,"twenty":-23.969543,"median":-17.448232,"eighty":-5.926617,"marketCap":1414019470},{"date":"2026-06-12","current":-42.561609,"twenty":-25.529539,"median":-17.587169,"eighty":-5.93225,"marketCap":1533920387},{"date":"2026-06-18","current":-44.775363,"twenty":-30.958305,"median":-17.712792,"eighty":-5.936756,"marketCap":1613704081},{"date":"2026-06-26","current":-43.19947,"twenty":-32.893633,"median":-17.963339,"eighty":-5.951139,"marketCap":1556908909},{"date":"2026-07-02","current":-43.28702,"twenty":-34.942293,"median":-18.108694,"eighty":-5.953151,"marketCap":1560064197},{"date":"2026-07-10","current":-47.326808,"twenty":-35.535865,"median":-18.432772,"eighty":-5.955718,"marketCap":1705658168},{"date":"2026-07-17","current":-39.472359,"twenty":-37.456217,"median":-18.865336,"eighty":-5.96031,"marketCap":1422583821},{"date":"2026-07-24","current":-41.861212,"twenty":-38.129098,"median":-19.056573,"eighty":-5.968707,"marketCap":1508678089},{"date":"2026-07-31","current":-43.999924,"twenty":-38.804481,"median":-19.345886,"eighty":-5.971132,"marketCap":1585757250},{"date":"2026-08-07","current":-49.440506,"twenty":-39.282531,"median":-19.37634,"eighty":-6.008114,"marketCap":1781835819},{"date":"2026-08-14","current":-86.93668,"twenty":-40.880657,"median":-19.444862,"eighty":-6.039269,"marketCap":2106997387},{"date":"2026-08-21","current":-78.558866,"twenty":-41.886226,"median":-19.559064,"eighty":-6.073792,"marketCap":1903952668},{"date":"2026-08-28","current":-77.942567,"twenty":-42.501575,"median":-19.616165,"eighty":-6.102974,"marketCap":1889016045},{"date":"2026-09-01","current":-73.474399,"twenty":-42.526647,"median":-19.764628,"eighty":-6.109088,"marketCap":1780725528}],"updateTime":1788374947732},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SEPN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664085621","title":"Septerna to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664085621","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664085621?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug di","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354043/0/en/septerna-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN","BK4599","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663004936","title":"Septerna (SEPN) Names A New CMO, Is The Upside Already Priced In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663004936","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663004936?lang=en_us&edition=fundamental","pubTime":"2026-08-30 15:19","pubTimestamp":1788074374,"startTime":"0","endTime":"0","summary":"Septerna (SEPN) has drawn fresh investor attention after appointing Rajiv Patni, M.D., as Chief Medical Officer. The move raises new questions about how his track record in drug development could influence the company’s clinical priorities and risk profile.\nSepterna’s latest executive change comes after a strong run in the stock, with the share price at US$38.91 and a year to date share price return of 39.06%, alongside a very large 1 year total shareholder return of 221.57%.\nSpot momentum in...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/septerna-sepn-names-a-new-cmo-is-the-upside-already-priced-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/septerna-sepn-names-a-new-cmo-is-the-upside-already-priced-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662656827","title":"Is Septerna (SEPN) Elevating Its Clinical Strategy With a Veteran Regulatory Leader at the Helm?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662656827","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662656827?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:29","pubTimestamp":1787700568,"startTime":"0","endTime":"0","summary":"Septerna, Inc. recently appointed Rajiv Patni, M.D., as Chief Medical Officer, adding a physician-scientist with more than 25 years of global biopharmaceutical leadership experience across research, development, regulatory, and medical affairs roles.\nHis track record contributing to 10 regulatory approvals or label expansions and leadership roles at companies that were later acquired may influence how investors view Septerna’s ability to advance its pipeline and execute on clinical...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/is-septerna-sepn-elevating-its-clinical-strategy-with-a-vete","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/is-septerna-sepn-elevating-its-clinical-strategy-with-a-vete","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662734860","title":"Press Release: Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734860","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734860?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:01","pubTimestamp":1787659260,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug disc","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","BK4599","BK4022","SEPN","BK4232","R","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660420429","title":"Septerna is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660420429","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660420429?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:57","pubTimestamp":1787165820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SEPN/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660242653","title":"Septerna price target raised to $48 from $38 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660242653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660242653?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:36","pubTimestamp":1787146569,"startTime":"0","endTime":"0","summary":"JPMorgan raised the firm’s price target on Septerna (SEPN) to $48 from $38 and keeps an Overweight rating on the shares. Published first on TheFly ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/septerna-price-target-raised-to-48-from-38-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/septerna-price-target-raised-to-48-from-38-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660438984","title":"U.S. Research Roundup-Cogent Communications, Dollar Tree, Home Depot","url":"https://stock-news.laohu8.com/highlight/detail?id=2660438984","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660438984?lang=en_us&edition=fundamental","pubTime":"2026-08-19 15:50","pubTimestamp":1787125815,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Cogent Communications, Dollar Tree, Home DepotAug 19 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4N44G0KE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAND","HONA","IDEF","MADE","SJM","KROP","HD","FOWF","SPSC","BPAY","AMLX","EVX","NUKX","SEPN","FTAG","RTH","KEYS","COR","WDGF","GPN","TRUM","ARMK","DLTR","ECL","NOC","ELF","VEGI","AD","HSIC","D","RSPS","BZZ","ZAP","TDS","TBLU","HWAY","MCK","HOMZ","ONCY","CGW","FSPC","CCOI","MRCY","PKB","AGCO","MD","SHLD","DE","CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660617069","title":"Septerna, Inc. (SEPN) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2660617069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660617069?lang=en_us&edition=fundamental","pubTime":"2026-08-17 01:55","pubTimestamp":1786902913,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Septerna, Inc. today and set a price target of $46.00. According to TipRanks, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/septerna-inc-sepn-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/septerna-inc-sepn-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659194265","title":"Truist Financial Reaffirms Their Buy Rating on Septerna, Inc. (SEPN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659194265","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659194265?lang=en_us&edition=fundamental","pubTime":"2026-08-14 10:25","pubTimestamp":1786674323,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Septerna, Inc. yesterday and set a price target of $59.00. Devarakonda cov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-reaffirms-their-buy-rating-on-septerna-inc-sepn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-reaffirms-their-buy-rating-on-septerna-inc-sepn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659519534","title":"Septerna President, COO Elizabeth Bhatt Sells 25,000 Shares Worth $1.1 Million Under 10b5-1 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2659519534","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659519534?lang=en_us&edition=fundamental","pubTime":"2026-08-14 07:00","pubTimestamp":1786662045,"startTime":"0","endTime":"0","summary":"Septerna President, COO Elizabeth Bhatt sells 25,000 shares worth $1.1 million under 10b5-1 planSepterna President and COO Elizabeth Bhatt sold 25,000 common shares at USD 44 on Aug. 11, 2026.The sale","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL3kMLbN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Septerna President, COO Elizabeth Bhatt Sells 25,000 Shares Worth $1.1 Million Under 10b5-1 Plan","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659030183","title":"Does Septerna (SEPN) Pair Narrowing Losses With A Cash Runway That Truly Supports Its Pipeline Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2659030183","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659030183?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:26","pubTimestamp":1786566410,"startTime":"0","endTime":"0","summary":"In the past quarter, Septerna, Inc. reported second-quarter 2026 sales of US$26.75 million versus US$0.12 million a year earlier, with net loss narrowing to US$13.03 million and basic loss per share from continuing operations improving to US$0.29 from US$0.56.\nAlongside these results, Septerna highlighted progress across its early-stage clinical programs and reiterated that its cash position is expected to fund operations into 2029, underscoring management’s current focus on advancing its...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/does-septerna-sepn-pair-narrowing-losses-with-a-cash-runway","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-sepn/septerna/news/does-septerna-sepn-pair-narrowing-losses-with-a-cash-runway","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658976604","title":"Septerna, Inc. : Wells Fargo Raises Target Price to $50 from $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2658976604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658976604?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:18","pubTimestamp":1786529904,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nAZN4TDHW0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SEPN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927512","title":"Wall Street Analysts Are Bullish on Top NA Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927512","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658927512?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:00","pubTimestamp":1786521629,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Septerna, Inc. (SEPN) and Black Rock Coffee Bar, Inc. Class ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-na-picks-blurbs-news-20?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-na-picks-blurbs-news-20?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BRCB","SEPN","BK4209","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919618","title":"Septerna is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919618","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919618?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:30","pubTimestamp":1786458600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SEPN/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658913650","title":"Septerna price target raised to $49 from $45 at Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2658913650","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658913650?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:01","pubTimestamp":1786453271,"startTime":"0","endTime":"0","summary":"Raymond James raised the firm’s price target on Septerna (SEPN) to $49 from $45 and keeps a Strong Buy rating on the shares. The firm updated its m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/septerna-price-target-raised-to-49-from-45-at-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/septerna-price-target-raised-to-49-from-45-at-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SEPN","RJF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992565","title":"C4 Therapeutics Q2 Revenue Beats Estimates, Helped by Roche Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992565","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992565?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:08","pubTimestamp":1786446516,"startTime":"0","endTime":"0","summary":"C4 Therapeutics Q2 revenue beats estimates, helped by Roche collaborationOverviewUS biopharma firm's Q2 revenue rose slightly, beating analyst expectationsQ2 net loss per share was $0.18, better than ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480D3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4505","BK4588","BBIO","BK4139","CCCC","SEPN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658795134","title":"Septerna Q2 Loss Narrows, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2658795134","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658795134?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:26","pubTimestamp":1786393576,"startTime":"0","endTime":"0","summary":"Septerna (SEPN) reported Q2 loss late Monday of $0.29 per diluted share, narrower from $0.56 a year earlier.Analysts polled by FactSet expected a loss of $0.43.Revenue for the quarter ended June 30 was $26.7 million, up from $119,000 a year earlier.Analysts expected $19.2 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959255","title":"Septerna, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959255","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959255?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:17","pubTimestamp":1786393057,"startTime":"0","endTime":"0","summary":"Septerna, Inc. reports results for the quarter ended June 30 - Earnings SummarySepterna, Inc.SEPN.OQreported a quarterly adjusted loss of 29 cents per share for the quarter ended June 30, higher than ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N4471VK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658254959","title":"Earnings Flash (SEPN) Septerna Posts Q2 Loss Per Share $0.29, vs. FactSet Est of $0.43 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658254959","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658254959?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:16","pubTimestamp":1786392982,"startTime":"0","endTime":"0","summary":"Earnings Flash (SEPN) Septerna Posts Q2 Loss Per Share $0.29, vs. FactSet Est of $0.43 Loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SEPN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658295935","title":"Septerna Q2 Revenue Beats Analyst Estimates, Driven by Novo Nordisk Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2658295935","media":"Reuters","labels":["corporation","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658295935?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:08","pubTimestamp":1786392529,"startTime":"0","endTime":"0","summary":"Septerna Q2 revenue beats analyst estimates, driven by Novo Nordisk partnershipOverviewUS biotechnology firm's Q2 revenue rose and beat analyst expectationsNet loss for Q2 narrowed compared to prior y","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470V5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTX","BK4121","BK4505","LFSC","CANC","COGT","QTRX","SEPN","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":90,"code":"91000000","status":"200"}]}}